The University at Buffalo’s Philips MR7700 3 Tesla scanner continues to be a cornerstone of cutting-edge biomedical research and clinical innovation across the university and the greater Western New York community.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.
To study how a key chemical neuromodulator affects signaling in the brain's cortex, Garrett Neske, PhD, has received a three-year, $300,000 grant from the Whitehall Foundation, a nonprofit organization funding basic neurobiology research.
